IP Library Granted Patent US 10,081,757
Granted Patent B2
US 10,081,757 · App. 14/648,391 · Granted Sep 25, 2018

Shale swelling inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,757
App. No.
14/648,391
Granted
Sep 25, 2018
Kind
B2
Abstract

The present invention provides amidic polymers, which exhibit shale swelling inhibitor activity having improved biodegradability. The amidic polymers of the invention may be employed in a wide variety of compositions, particularly in subterranean drilling operations. Non-limiting generic structures of the amidic polymers are set out below: formula (1) wherein R 1 -R 3 and integers m and n are defined herein.

Claims (16)

1. An amidic polymer comprising a (a) polymer having a hydroxyl group reacted with a (b) compound having an epoxy group and an unsaturated moiety to provide a reactive unsaturated intermediate polymer; wherein the reactive unsaturated intermediate polymer is further reacted with a (c) vinyl amide to provide the amidic polymer,

wherein the hydroxyl group of the (a) polymer reacts with the epoxy group of the (b) compound and the unsaturated moiety of the (b) compound reacts with the vinyl moiety of the (c) vinyl amide to form a new carbon-carbon bond.

2. The amidic polymer according to claim 1 , wherein the (a) polymer having a hydroxyl group is selected from the group consisting of a partially hydrolyzed poly(vinyl acetate), a poly(vinyl alcohol), a polysaccharide, and mixtures thereof.

3. The amidic polymer according to claim 2 , wherein the polysaccharide is derived from a cellulose, a hydroxyethyl cellulose, a carboxymethyl cellulose, a hydroxyethyl cellulose, a hydropropyl cellulose, a hydroxypropyl methyl cellulose, an ethyl cellulose, a carrageenan, a chitosan, a chondroitin sulfate, a heparin, a hyaluronic acid, a starch, a chitin, a perctin, a guar, a xanthan, a dextran, a welan gum, a gellan gum, a diutan, a pullulana, or a combination thereof.

4. The amidic polymer according to claim 1 , wherein the (b) compound having an epoxy group and an unsaturated moiety is selected from the group consisting of a glycidyl methacrylate, a glycidyl acrylate], a glycidyl ethyl acrylate, a allyl glycidyl ether, a glycidyl methacrylamide, a glycidyl ethylacrylamide, a glycidyl acrylamide, and mixtures thereof.

5. The amidic polymer according to claim 1 , wherein the (c) vinyl amide is selected from the group consisting of N-vinyl pyrrolidone; N-vinyl piperidone; N-vinyl caprolactam; N-vinyl-3-methyl pyrrolidone; N-vinyl-4-methyl pyrrolidone; N-vinyl-5-methyl pyrrolidone; N-vinyl-3-ethyl pyrrolidone; N-vinyl-3-butyl pyrrolidone; N-vinyl-3,3-dimethyl pyrrolidone; N-vinyl-4,5-dimethyl pyrrolidone; N-vinyl-5,5-dimethyl pyrrolidone; N-vinyl-3,3,5-trimethyl pyrrolidone; N-vinyl-5-methyl-5-ethyl pyrrolidone; N-vinyl-3,4,5-trimethyl-3-ethyl pyrrolidone; N-vinyl-6-methyl-2-piperidone; N-vinyl-6-ethyl-2-piperidone; N-vinyl-3,5-dimethyl-2-piperidone; N-vinyl-4,4-dimethyl-2-piperidone; N-vinyl-6-propyl-2-piperidone; N-vinyl-3-octyl piperidone; N-vinyl-7-methyl caprolactam; N-vinyl-7-ethyl caprolactam; N vinyl-4-isopropyl caprolactam; N-vinyl-5-isopropyl caprolactam; N-vinyl-4-butyl caprolactam; N-vinyl formamide; N-vinyl acetamide; N-(2,2-dichloro-vinyl)-propionamide; N-ethenyl acetamide; cis-N-propenyl acetamide; N-vinyl-N-methyl acetamide; N-vinyl-N,N-propyl propionamide; N-acryloyl piperidone; N-acryloyl pyrrolidone; ethyl acryloyl pyrrolidone; methyl acryloyl pyrrolidone; N-acryloyl caprolactam; ethyl acryloyl caprolactam; methyl acryloyl caprolactam; N-cyclohexylacrylamide; N-cyclopentylacrylamide; acrylamide, N-butoxymethylacrylamide; N,N-dibutylacrylamide; N-butylacrylamide; diacetoneacrylamide; N—(N,N-dimethylamino)ethyl acrylamide; N,N-diethylacrylamide; N,N-dimethylacrylamide; N-dodecylmethacrylamide; N-ethylacrylamide; N-ethylmethacrylamide; N-isopropylacrylamide; N-isopropylmethacrylamide; β,β-N,N-tetramethylacrylamide; N-methylolacrylamide; N-methyl acrylamide; N-octadecylacrylamide; N-octylacrylamide; N-phenylacrylamide; trichloroacrylamide; and mixtures thereof.

6. The amidic polymer according to claim 1 , wherein the polymer is represented by the structure:

wherein R 1 is derived from a polymer having a hydroxyl group; R 2 is selected from the group consisting of —O—(C═O)—, —O—C—, and —NH—(C═O)—; R 3 is selected from the group consisting of hydrogen and a C 1 -C 4 alkyl group; n is an integer ranging from 1 to 3; and m is an integer ranging from 1 to about 1,000,000.

7. The amidic polymer according to claim 6 , wherein R 1 is derived from a polymer having a hydroxyl group selected from the group consisting of a partially hydrolyzed poly(vinyl acetate), a poly(vinyl alcohol), a polysaccharide, and mixtures thereof.

8. The amidic polymer according to claim 7 , wherein the polysaccharide is derived from a cellulose, a hydroxyethyl cellulose, a carboxymethyl cellulose, a hydroxyethyl cellulose, a hydropropyl cellulose, a hydroxypropyl methyl cellulose, an ethyl cellulose, a carrageenan, a chitosan, a chondroitin sulfate, a heparin, a hyaluronic acid, a starch, a chitin, a perctin, a guar, a xanthan, a dextran, a welan gum, a gellan gum, a diutan, a pullulana, or a combination thereof.

9. The amidic polymer according to claim 6 , wherein R 2 is —O—(C═O)—.

10. The amidic polymer according to claim 6 , wherein R 3 is hydrogen or methyl.

11. The amidic polymer according to claim 6 , wherein n is an integer ranging from 1 to 2.

12. The amidic polymer according to claim 6 , wherein m is an integer ranging from 1 to about 750,000.

13. The amidic polymer according to claim 6 , wherein the polymer is selected from the group of structures consisting of:

wherein x is an integer ranging from 1 to about 1,000,000; y is an integer ranging from 1 to about 1,000,000; w is an integer ranging from 1 to about 1,000,000; o is an integer ranging from 1 to about 1,000,000; and z is an integer ranging from 1 to about 1,000,000.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2015
From: LEI, CUIYUE; MUSA, OSAMA M.
To: ISP INVESTMENTS INC.
Reel/Frame 035743/0034 →